MCID: SNG003
MIFTS: 30

Single Ventricular Heart

Categories: Rare diseases

Aliases & Classifications for Single Ventricular Heart

MalaCards integrated aliases for Single Ventricular Heart:

Name: Single Ventricular Heart 52 37
Single Ventricle 52 6
Single Ventricle Defect 6

Classifications:



Summaries for Single Ventricular Heart

MalaCards based summary : Single Ventricular Heart, also known as single ventricle, is related to pulmonary atresia with intact ventricular septum and critical congenital heart disease. The drugs Ambrisentan and Dobutamine have been mentioned in the context of this disorder. Affiliated tissues include heart, liver and brain.

Related Diseases for Single Ventricular Heart

Diseases related to Single Ventricular Heart via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 200)
# Related Disease Score Top Affiliating Genes
1 pulmonary atresia with intact ventricular septum 11.5
2 critical congenital heart disease 11.4
3 holoprosencephaly 1 11.3
4 polysyndactyly with cardiac malformation 11.1
5 microphthalmia, syndromic 9 11.1
6 hypoplastic left heart syndrome 10.7
7 heart septal defect 10.5
8 univentricular heart 10.5
9 tricuspid atresia 10.5
10 heart disease 10.5
11 heterotaxy 10.5
12 dextro-looped transposition of the great arteries 10.4
13 ventricular septal defect 10.3
14 protein-losing enteropathy 10.3
15 subvalvular aortic stenosis 10.3
16 atrioventricular septal defect 10.3
17 cardiac arrest 10.3
18 pulmonary hypertension 10.3
19 right atrial isomerism 10.2
20 double outlet right ventricle 10.2
21 congestive heart failure 10.2
22 mitral atresia 10.2
23 dextrocardia 10.2
24 patent ductus arteriosus 1 10.1
25 coarctation of aorta 10.1
26 atrioventricular block 10.1
27 arteriovenous malformation 10.1
28 atrial heart septal defect 10.1
29 tricuspid valve insufficiency 10.1
30 complete atrioventricular canal 10.1
31 down syndrome 10.0
32 visceral heterotaxy 10.0
33 bronchitis 10.0
34 double discordia 10.0
35 plastic bronchitis 10.0
36 atrial standstill 1 10.0
37 pheochromocytoma 10.0
38 tetralogy of fallot 10.0
39 adrenal gland pheochromocytoma 10.0
40 eisenmenger syndrome 10.0
41 pulmonic stenosis 9.9
42 paraganglioma 9.9
43 sinoatrial node disease 9.9
44 sick sinus syndrome 9.9
45 pulmonary valve stenosis 9.9
46 chromosomal triplication 9.9
47 mesocardia 9.9
48 right aortic arch 9.9
49 cardiac conduction defect 9.9
50 attention deficit-hyperactivity disorder 9.9

Graphical network of the top 20 diseases related to Single Ventricular Heart:



Diseases related to Single Ventricular Heart

Symptoms & Phenotypes for Single Ventricular Heart

Drugs & Therapeutics for Single Ventricular Heart

Drugs for Single Ventricular Heart (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 89)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Ambrisentan Approved, Investigational Phase 4 177036-94-1 6918493
2
Dobutamine Approved Phase 4 34368-04-2 36811
3
Carvedilol Approved, Investigational Phase 4 72956-09-3 2585
4
Eplerenone Approved Phase 4 107724-20-9 150310 443872
5 Antioxidants Phase 4
6 Adrenergic beta-Antagonists Phase 4
7 Adrenergic alpha-1 Receptor Antagonists Phase 4
8 Calcium, Dietary Phase 4
9 calcium channel blockers Phase 4
10 Hormone Antagonists Phase 4
11 Hormones Phase 4
12 Mineralocorticoids Phase 4
13 Mineralocorticoid Receptor Antagonists Phase 4
14 diuretics Phase 4
15 Diuretics, Potassium Sparing Phase 4
16
Calcium Nutraceutical Phase 4 7440-70-2 271
17
Enalapril Approved, Vet_approved Phase 3 75847-73-3 40466924 5362032
18
Enalaprilat Approved Phase 3 76420-72-9 6917719
19
Colchicine Approved Phase 2, Phase 3 64-86-8 2833 6167
20
Aminophylline Approved Phase 3 317-34-0 9433
21
Udenafil Approved, Investigational Phase 3 268203-93-6 6918523
22
Rivaroxaban Approved Phase 3 366789-02-8
23
Aspirin Approved, Vet_approved Phase 3 50-78-2 2244
24
Sodium citrate Approved, Investigational Phase 3 68-04-2
25
Citric acid Approved, Nutraceutical, Vet_approved Phase 3 77-92-9 311
26 Angiotensin-Converting Enzyme Inhibitors Phase 3
27 Hemostatics Phase 2, Phase 3
28 Vasopressins Phase 2, Phase 3
29 Vasoconstrictor Agents Phase 2, Phase 3
30 Arginine Vasopressin Phase 2, Phase 3
31 Coagulants Phase 2, Phase 3
32 Phosphodiesterase Inhibitors Phase 3
33 Protective Agents Phase 3
34 Cardiotonic Agents Phase 3
35 Tubulin Modulators Phase 2, Phase 3
36 Antimitotic Agents Phase 2, Phase 3
37
protease inhibitors Phase 3
38 HIV Protease Inhibitors Phase 3
39 Antirheumatic Agents Phase 3
40 Antithrombins Phase 3
41 Antithrombin III Phase 3
42 Fibrinolytic Agents Phase 3
43 Serine Proteinase Inhibitors Phase 3
44 Factor Xa Inhibitors Phase 3
45 Analgesics, Non-Narcotic Phase 3
46 Analgesics Phase 3
47 Cyclooxygenase Inhibitors Phase 3
48 Antipyretics Phase 3
49 Anti-Inflammatory Agents Phase 3
50 Anti-Inflammatory Agents, Non-Steroidal Phase 3

Interventional clinical trials:

(show top 50) (show all 137)
# Name Status NCT ID Phase Drugs
1 Improved Diagnosis of Congenital Heart Disease by Magnetic Resonance Imaging Using Vasovist Unknown status NCT00668824 Phase 4 Vasovist
2 Response to Sildenafil in Patients With Fontan Physiology, A Pressure-volume Loop Analysis Completed NCT01815502 Phase 4
3 The Effects of Ambrisentan on Exercise Capacity in Fontan Patients Completed NCT01971580 Phase 4 Ambrisentan
4 Effect of Carvedilol on Exercise Performance in Fontan Patients Completed NCT02946892 Phase 4 Carvedilol;Placebo
5 Eplerenone to Prevent Myocardial Fibrosis in Congenital Heart Disease Terminated NCT01971593 Phase 4 Eplerenone
6 Efficacy and Safety Study of Autologous Cardiac Stem Cells (JRM-001) Treated After Reconstructive Surgery in Pediatric Patients With Congenital Heart Disease: A Multicenter Randomized Single-blind Parallel-group Study Unknown status NCT02781922 Phase 3
7 The Influence of Postoperative Systemic Oxygen Transport on Neurologic and Functional Outcomes in Infants Undergoing Single Ventricle Palliation With Norwood and Hybrid Management Strategies Unknown status NCT01134302 Phase 3
8 Trial of Right Ventricular Versus Modified Blalock-Taussig Shunt in Infants With Single Ventricle Defect Undergoing Staged Reconstruction (A Trial Conducted by the Pediatric Heart Network) Completed NCT00115934 Phase 3
9 Trial of ACE Inhibition in Infants With Single Ventricle (A Trial Conducted by the Pediatric Heart Network) Completed NCT00113087 Phase 3 Enalapril;Placebo
10 Fontan Udenafil Exercise Longitudinal Assessment Trial (FUEL) Completed NCT02741115 Phase 3 Udenafil;Placebo
11 The Acute Effects of the Angiotensin-converting Enzyme Inhibitor Enalaprilat on Flow Distribution After the Bidirectional Cavopulmonary Connection Completed NCT00741156 Phase 3 Enalaprilat
12 Examination of Safety and Effectiveness of IK-3001 (Nitric Oxide for Inhalation) in Japanese Subjects With Pulmonary Hypertension Associated With Cardiac Surgery - Multi-Center, Open-Label, Clinical Study Completed NCT01959828 Phase 3 IK-3001
13 Multicenter, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy/Safety of CY-1503 (Cylexin) in Prevention of Reperfusion Injury in Neonates/Infants Undergoing Hypothermic Cardiopulmonary Bypass Completed NCT00226369 Phase 2, Phase 3 CY-1503
14 A Phase III Single-Blind, Randomized, Placebo Controlled, Clinical Trial to Determine the Safety and Efficacy of Intravenous L-Citrulline Versus Placebo in Children Undergoing Cardiopulmonary Bypass Completed NCT00335244 Phase 3 L-citrulline;Placebo of intravenous L-citrulline
15 Use of Arginine Vasopressin in Early Postoperative Management After Fontan Palliation Completed NCT03088345 Phase 2, Phase 3 Vasopressin, Arginine;Placebos
16 Prospective Evaluation Of Biventricular Pacing In Patients With Left Ventricular Dysfunction After Cardiovascular Surgery Completed NCT00321295 Phase 3
17 Colchicine in Postoperative Fontan Patients (CPFP) Recruiting NCT03575572 Phase 2, Phase 3 Colchicine
18 The Effect of Aminophylline on Preventing Acute Kidney Injury in Neonates and Infants With Congenital Heart Disease Undergoing Open Heart Surgery Recruiting NCT03897335 Phase 3 Aminophylline;Placebos
19 A Phase III Extension Study of Udenafil in Adolescents With Single Ventricle Physiology After Fontan Palliation Active, not recruiting NCT03013751 Phase 3 Udenafil
20 A Prospective, Open-Label, Active-Controlled Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Efficacy of Rivaroxaban for Thromboprophylaxis in Pediatric Subjects 2 to 8 Years of Age After the Fontan Procedure Active, not recruiting NCT02846532 Phase 3 Rivaroxaban;Acetylsalicylic Acid
21 Phosphodiesterase-type 5 Inhibitors in Adult and Adolescent Patients With Univentricular Heart Disease: a Multi-center, Randomized, Double Blind Phase III Study Not yet recruiting NCT03997097 Phase 3 Sildenafil;Placebos
22 A Randomized Trial of Closed Loop Stimulation After Epicardial Pacemaker Implantation for Congenital Heart Disease Not yet recruiting NCT03361189 Phase 2, Phase 3
23 The Effect of Selective Pulmonary Vasodilation on Ventricular Afterload and Ventricular-arterial Coupling in Patients With Fontan Physiology and Validation of Echocardiographic Measures of Systolic and Diastolic Function. Withdrawn NCT01607983 Phase 3 inhaled nitric oxide
24 Bosentan Therapy for High Risk Staged Fontan Procedure in Children With Functional Single Ventricle Completed NCT01662037 Phase 2 Bosentan
25 A Phase I/II Dose Escalation Trial of Udenafil in Adolescents With Single Ventricle Physiology After Fontan Palliation Completed NCT02201342 Phase 1, Phase 2 Udenafil
26 Safety, Pharmacokinetics (PK) and Hemodynamic Effects of Ambrisentan in Single Ventricle Pediatric Patients Completed NCT02080637 Phase 2 Ambrisentan
27 Treatment With Endothelin Antagonist to Tcpc Patients; a Multicenter, Randomized, Prospective Study Measuring Maximal O2 Uptake in Ergometer Bicycle Test Completed NCT01292551 Phase 2 Bosentan;Placebo
28 Phase I/II Clinical Trial to Determine the Pharmacokinetics and Safety Profile of Citrulline in Children Undergoing Cardiopulmonary Bypass Completed NCT00201214 Phase 1, Phase 2 Citrulline
29 The Sildenafil After Fontan Operation Study Completed NCT00507819 Phase 2 Sildenafil;Placebo
30 A Prospective, Randomized, Controlled Clinical Trial Comparing Two Transfusion Strategies in Pediatric Patients Undergoing Cavopulmonary Connection. Completed NCT00350220 Phase 2
31 Phase IB Double Blind, Randomized, Placebo Controlled Clinical Trial to Determine the Pharmacokinetics and Safety of a Revised Protocol of Intravenous L-Citrulline (Citrupress®) Versus Placebo in Children Undergoing Cardiopulmonary Bypass Completed NCT01120964 Phase 1, Phase 2 Intravenous L-Citrulline;Placebo of Intravenous L-Citrulline
32 Phase IIb Study of Intramyocardial Injection of Autologous Umbilical Cord Blood Derived Mononuclear Cells During Stage II Surgical Repair of Right Ventricular Dependent Variants of Hypoplastic Left Heart Syndrome (AutoCell-S2) Recruiting NCT03779711 Phase 2
33 Mesoblast Stem Cell Therapy for Patients With Single Ventricle and Borderline Left Ventricle Recruiting NCT03079401 Phase 1, Phase 2
34 Maternal Hyperoxygenation in Congenital Heart Disease Recruiting NCT03136835 Phase 1, Phase 2 Maternal Hyperoxygenation
35 Impact of Empiric Nesiritide or Milrinone Infusion on Early Postoperative Recovery Following Fontan Surgery: a Randomized, Double-blind, Placebo-controlled Clinical Trial Terminated NCT00543309 Phase 2 nesiritide;milrinone;placebo
36 Parenteral Phenoxybenzamine During Congenital Heart Disease Surgery Withdrawn NCT00770705 Phase 2 Phenoxybenzamine
37 Safety, Pharmacokinetics and Hemodynamic Efficacy of Sildenafil in Single Ventricle Patients Completed NCT01169519 Phase 1 Sildenafil by injection;Sildenafil by injection;Sildenafil by injection;Sildenafil by injection
38 Phase I Study of Cardiac Progenitor Cell Therapy in Patients With Single Ventricle Physiology Completed NCT01273857 Phase 1
39 A Pilot Study Investigating the Clinical Use of Tissue Engineered Vascular Grafts in Congenital Heart Surgery Completed NCT01034007 Phase 1
40 Effect of Tadalafil on Exercise Capacity in Pediatric Fontan Patients Completed NCT01291069 Phase 1 Tadalafil Citrate;Sugar pill
41 Liothyronine in Children With Single Ventricle Congenital Cardiac Malformations Undergoing the Fontan Procedure Completed NCT00004828 Phase 1 liothyronine I 131
42 Feasibility and Efficacy Of Negative Pressure Ventilation in Fontan populatioN: Cardiovascular Flow Assessment by Magnetic Resonance Imaging Completed NCT03251742 Phase 1
43 The Acute Effects of the Prostaglandin (Alprostadil) on Cerebral and Pulmonary Flow After the Bidirectional Cavopulmonary Connection Recruiting NCT04054115 Phase 1 Alprostadil 5 MCG Injection
44 " An Open Label Pilot Study Evaluating Safety and Evidence of Therapeutic Effect of IV Admin of 2-0, 3-0 Desulfated Heparin, Treatment of Exacerbation of Protein Losing Enteropathy (PLE) Associated With Single Ventricle Palliative Surgery" Terminated NCT01161641 Phase 1 ODSH at 0.125 mg/kg/h;ODSH at 0.375 mg/kg/h;ODSH at 0.250 mg/kg/h
45 Biomarkers for Feeding Intolerance in Infants With Complex Congenital Heart Defects Undergoing Single Ventricle Staged Palliation Unknown status NCT02995577
46 Cardio Pulmonary Exercise Testing in Patients Post the Fontan Palliation in Comparison With Patients With Repaired Congenital Heart Disease and Healthy Volunteers. Unknown status NCT02659462
47 Frailty in Children With Cardiac Disease: A Pilot Study Unknown status NCT02999438
48 Long-term Effects on Pulmonary Function in Post- Fontan Operation Unknown status NCT01413308
49 Multimodality Biomarkers for Noninvasive Assessment of the Fontan Patient Unknown status NCT03263312
50 Fenestrated Vs Non Fenestrated Extra-Cardiac Total Cavo-pulmonary Connection in Patients With Standard Preoperative Risk Profiles, A Prospective Randomized Study Unknown status NCT03503032

Search NIH Clinical Center for Single Ventricular Heart

Cell-based therapeutics:


LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database
Read about Single Ventricular Heart cell therapies at LifeMap Discovery.
Stem-cell-based therapeutic approaches for Single Ventricular Heart:
Cardiac progenitor cells for single-ventricle anomalies
Embryonic/Adult Cultured Cells Related to Single Ventricular Heart:
Cardiac progenitor cells PMIDs: 17502484 14530411 18754813
Cardiac stem cells PMIDs: 17502484 14530411 18754813

Genetic Tests for Single Ventricular Heart

Anatomical Context for Single Ventricular Heart

MalaCards organs/tissues related to Single Ventricular Heart:

40
Heart, Liver, Brain, Testes, Lung, Kidney, Endothelial

Publications for Single Ventricular Heart

Articles related to Single Ventricular Heart:

(show top 50) (show all 3210)
# Title Authors PMID Year
1
The Pediatric Heart Network Residual Lesion Score Study: Design and objectives. 61
31870553 2020
2
Heart failure with reduced and preserved ejection fraction in adult congenital heart disease. 61
31873841 2020
3
Exercise testing for assessment of heart failure in adults with congenital heart disease. 61
31686282 2020
4
Toddler Neurodevelopmental Outcomes Are Associated With School-Age IQ in Children With Single Ventricle Physiology. 61
31698030 2020
5
Impact of aortopulmonary collateral flow and single ventricle morphology on longitudinal hemodynamics in Fontan patients: A serial CMR study. 61
32037131 2020
6
Diagnosis and management of the adult patient with a failing Fontan circulation. 61
32185561 2020
7
Maternal Predictors of Disparate Outcomes in Children With Single Ventricle Congenital Heart Disease. 61
32515252 2020
8
Caudate nuclei volume alterations and cognition and mood dysfunctions in adolescents with single ventricle heart disease. 61
32530059 2020
9
In silico features of ADAMTS13 contributing to plasmatic ADAMTS13 levels in neonates with congenital heart disease. 61
32531546 2020
10
Treatment and outcome of plastic bronchitis in single ventricle patients: a systematic review. 61
32451550 2020
11
Estimating the optimal timing of surgery from observational data. 61
32506431 2020
12
Recurrent Pulmonary Artery Interventions Following the Norwood Procedure are not associated with Conduit Type. 61
32512161 2020
13
The Spectrum of Cardiac Anomalies Associated with Heterotaxy: A Single-Center Study of a Large Series Based on Computed Tomography. 61
32556488 2020
14
1.5 Ventricle Repair Using Left Ventricle as the Subpulmonary Ventricle. 61
32504613 2020
15
Single ventricle with atrioventricular valve regurgitation-ongoing challenges. 61
32504608 2020
16
Current status of pediatric mechanical circulatory support. 61
32304423 2020
17
Health related quality of life in children with congenital heart disease that undergo cardiac surgery during their first year of life. 61
32470251 2020
18
Longitudinal study of anthropometry in Fontan survivors: Pediatric Heart Network Fontan study. 61
32428726 2020
19
Hospital-Associated Venous Thromboembolism in a Pediatric Cardiac ICU: A Multivariable Predictive Algorithm to Identify Children at High Risk. 61
32343105 2020
20
Myosin heavy chain isoforms in the myocardium of the atrioventricular junction of Scyliorhinus canicula (Chondrichthyes, Carcharhiniformes). 61
32515493 2020
21
Prevalence of Sleep-Disordered Breathing in a Cohort of Adult Fontan Patients. 61
32577770 2020
22
Cardiac Magnetic Resonance-Derived Metrics Are Predictive of Liver Fibrosis in Fontan Patients. 61
31734244 2020
23
Atrioventricular Valve Regurgitation in Single Ventricle Heart Disease: A Common Problem Associated With Progressive Deterioration and Mortality. 61
32419552 2020
24
Use of Occlutech® atrial flow regulator in a single ventricle patient: a 3D view of a successful intervention. 61
32529256 2020
25
From Fontan to Anatomical Repair Sixteen Years Later. 61
32540435 2020
26
Deep Learning for Improved Risk Prediction in Surgical Outcomes. 61
32518246 2020
27
Effect of Atrioventricular Valve Repair on Multistage Palliation Results of Single Ventricle Defects. 61
32454017 2020
28
A patient with post-Fontan operation underwent left hepatectomy and caudate lobectomy for hepatocellular carcinoma: a case report. 61
32430849 2020
29
Normalization of hemodynamics is delayed in patients with a single ventricle after pediatric heart transplantation. 61
31767361 2020
30
Can ductus arteriosus morphology influence technique/outcome of stent treatment? 61
31951315 2020
31
Imaging of complications following Fontan circulation in children - diagnosis and surveillance. 61
32468285 2020
32
Prioritising transplantation for adult congenital heart disease, UK national data. 61
31604656 2020
33
A Comparison of Bidirectional Glenn vs. Hemi-Fontan Procedure: An Analysis of the Single Ventricle Reconstruction Trial Public Use Dataset. 61
32472151 2020
34
Abnormalities in cerebral hemodynamics and changes with surgical intervention in neonates with congenital heart disease. 61
31685276 2020
35
Central Vascular Thrombosis in Neonates with Congenital Heart Disease Awaiting Cardiac Intervention. 61
32472152 2020
36
Comparison of Fontan Surgical Options for Patients with Apicocaval Juxtaposition. 61
32377893 2020
37
Translation of the Frailty Paradigm from Older Adults to Children with Cardiac Disease. 61
32377892 2020
38
Outcomes of bidirectional cavopulmonary shunt in patients younger than 4 months of age. 61
31981361 2020
39
Progressive stiffening and relatively slow growth of the dilated ascending aorta in long-term Fontan survivors-Serial assessment for 15 years. 61
32389766 2020
40
Non-Newtonian Effects on Patient-Specific Modeling of Fontan Hemodynamics. 61
32372365 2020
41
Septal Flash-like Motion of the Earlier Activated Ventricular Wall Represents the Pathophysiology of Mechanical Dyssynchrony in Single-Ventricle Anatomy. 61
32089381 2020
42
Pleural Effusions After Congenital Cardiac Surgery Requiring Readmission: A Systematic Review and Meta-analysis. 61
32424719 2020
43
Pediatric Cardiology Specialist's Opinions Toward the Acceptability of Comfort Care for Congenital Heart Disease. 61
32419096 2020
44
Factors Associated With Survival Following Extracorporeal Cardiopulmonary Resuscitation in Children. 61
32294013 2020
45
Red Blood Cell Transfusion After Stage I Palliation Is Associated With Worse Clinical Outcomes. 61
32390527 2020
46
Risk factors of malnutrition in Chinese children with congenital heart defect. 61
32404077 2020
47
Adverse impact of univentricular pacing for the patient with functional single ventricle: successful conversion to cardiac resynchronization therapy. 61
32405970 2020
48
Angiotensin-Converting Enzyme Inhibitor Prescription for Patients With Single Ventricle Physiology Enrolled in the NPC-QIC Registry. 61
32384002 2020
49
Resuscitating the Chimney Graft to Innominate Artery for Straightforward Cannulation During Infancy. 61
31987822 2020
50
Modified extracardiac Fontan with a fenestrated pericardial patch. 61
32445209 2020

Variations for Single Ventricular Heart

ClinVar genetic disease variations for Single Ventricular Heart:

6 ‎‎ ‎‎
# Gene Name Type Significance ClinVarId dbSNP ID GRCh37 Pos GRCh38 Pos
1 NKX2-5 NM_004387.4(NKX2-5):c.809G>A (p.Cys270Tyr)SNV Conflicting interpretations of pathogenicity 156161 rs587782931 5:172659738-172659738 5:173232735-173232735
2 FOXP1 NM_032682.6(FOXP1):c.1702C>T (p.Pro568Ser)SNV Benign/Likely benign 55847 rs147674680 3:71019907-71019907 3:70970756-70970756

Expression for Single Ventricular Heart

Search GEO for disease gene expression data for Single Ventricular Heart.

Pathways for Single Ventricular Heart

GO Terms for Single Ventricular Heart

Sources for Single Ventricular Heart

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....